Pulmonary hypertension (PH) is a rare and fatal condition that leads to right heart failure and
death. The pathophysiology of PH and potential therapeutic approaches are yet unknown …

Pulmonary Hypertension (PH) is a global health problem that affects about 1% of the global
population. Animal models of PH play a vital role in unraveling the pathophysiological …

Pulmonary hypertension (PH) is an uncommon yet severe condition characterized by
sustained elevation of blood pressure in the pulmonary arteries. The delaying treatment can …

Pulmonary arterial hypertension (PAH) is a rare cardiovascular disease with very high
mortality rate. The currently available therapeutic strategies, which improve symptoms …

Pulmonary arterial hypertension (PAH) is a chronic cardiopulmonary syndrome with high
pulmonary vascular load and eventually causing RV heart failure even death. However, the …

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disease without a
clear mechanism or drugs for treatment. Therefore, it is crucial to reveal the underlying …

Idiopathic pulmonary arterial hypertension (IPAH) is a fatal cardiovascular disease event
with significant morbidity and mortality. However, its potential molecular mechanisms and …

Objectives: Idiopathic pulmonary arterial hypertension (IPAH) is a rare but severe lung
disorder, which may lead to heart failure and early mortality. However, little is known about …

Human health is at risk from pulmonary hypertension (PH), characterized by decreased
pulmonary vascular resistance and constriction of the pulmonary vessels, resulting in right …

Classification models such as Multi-Verse Optimization (MVO) play a vital role in disease
diagnosis. To improve the efficiency and accuracy of MVO, in this paper, the defects of MVO …